tradmap

CDLX Financials Cardlytics, Inc.

10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 2.6% per year over the past 5 years.
  • Operating margin has contracted, at -48.0% in the latest year.

Financial health

  • Total debt ($209M) exceeds cash ($49M); net debt is $160M.
  • Total debt has grown in line with revenue (3.7% vs 2.6% per year).
  • Operating income covered interest expense 9.6× in the latest year.
Revenue & net income
-$465M -$90M $285M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-168% -84% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-270% 664% 1598% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
ROEROA
Free cash flow (CFO − capex)
-$55M -$23M $9M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $147M $293M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$507M -$10M $486M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $212M -$104M 0.0% -48.0% 1598.0% -36.4% $9M $209M $49M
2024 $256M -$189M 0.0% -76.5% -270.0% -48.1% -$10M $259M $66M
2023 $285M -$135M 0.0% -47.5% -100.1% -23.5% -$852000 $258M $92M
2022 $277M -$465M 0.0% -165.2% -219.9% -67.3% -$55M $226M $122M
2021 $259M -$129M 0.0% -47.4% -18.6% -10.2% -$42M $184M $233M
2020 $187M -$55M 0.0% -28.9% -35.3% -13.1% -$13M $174M $293M
2019 $210M -$17M 0.0% -8.2% -12.0% -7.6% $3M $37000 $104M
2018 $151M -$53M 0.0% -27.2% -102.1% -34.5% -$25M $47M $40M
2017 $130M -$20M 0.0% -13.1% 9.4% -19.5% -$23M $57M $21M
2016 -$76M 34.9% -$34M $23M

Valuation over time

How the market has priced CDLX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 1.6 3.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is CDLX growing its revenue and profit?

Over the past 5 years, Cardlytics, Inc.'s revenue has grown 2.6% per year. These are computed facts, not advice.

How much debt does CDLX have?

As of FY2025, Cardlytics, Inc. reported $209M of total debt against $49M of cash; operating income covered interest expense 9.6×.

What is CDLX's profit margin?

In FY2025, gross margin was —, operating margin -48.0%, and net margin -49.0%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.